Ethos Financial Group, LLC
- SEC CIK
- 0001954242
- Latest filing
- Aug 7, 2026
URGN holding history
UroGen Pharma Ltd. in every 13F filed by Ethos Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
URGN overviewAll 13F holders of URGNFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −10,500−100.0% | Sold out | Holders |
| Q1 2025 | 10,500 | $111.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,500 | $111.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,500 | $133.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,500 | $176.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 10,500 | $158.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 10,500 | $158.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,500 | $147.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,500 | $97.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,500 | $97.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,500 | $93.1K | <0.1% | – | No prior filing | Holders |